Navigation Links
Cardiosolutions Names Dr. Lars Svensson Chief Surgical Officer
Date:11/21/2008

STOUGHTON, Mass., Nov. 21 /PRNewswire/ -- Cardiosolutions, Inc. (http://www.cardiosolutionsinc.com) has announced the appointment of Dr. Lars Svensson, M.D., Ph.D. to the position of Chief Surgical Officer. Dr. Svensson is currently the Director of the Center for Aortic Surgery and Director of the Marfan Syndrome and Connective Tissue Disorder Clinic in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic.

Cardiosolutions Inc. is developing its proprietary Percu-Pro(TM) System, a through the skin minimally invasive procedure for delivering a Mitra-Spacer(TM) into the heart for mitigating mitral regurgitation. This percutaneous system avoids open heart surgery, a difficult, risky, and costly procedure with an extended period of recovery which is the current standard treatment for mitral regurgitation. Mitral regurgitation is a condition in which the leaflets of the heart's mitral valve do not close correctly, allowing blood to improperly "backflow" from the lower pumping chamber (left ventricle) upward into the smaller upper chamber (left atrium). Debilitating chronic mitral regurgitation affects approximately 6% of women and 3% of men today. Cardiosolution's novel technology consists of a simple spacer, or plug, that is delivered to the mitral valve through a catheter inserted into a vein in the patient's leg. This spacer provides a sealing surface for the valve leaflets minimizing the backflow of blood into the left atrium.

In addition to its minimally invasive delivery system, Cardiosolutions is also exploring a surgical option for delivering its spacer technology. A surgical option will allow the Company to work with both the cardiac interventionalist, whose expertise involves catheter based therapies, and the cardiothoracic surgeon who is proficient in open chest procedures. The ability to engage physicians from both the interventionalist and surgical disciplines will allow a much wider patient population to benefit from Cardiosolution's novel spacer technology.

Dr. Svensson will lead the company's new effort in exploring the potential for the surgical delivery of its Mitra-Spacer(TM) technology which is done through a small chest incision. Dr. Svensson will also work alongside Dr. Thomas Piemonte Chief Medical Officer of Cardiosolutions Inc., in advancing the catheter based, percutaneous delivery system of the spacer. "Having Dr. Svensson as our Chief Surgical Officer is a tremendous asset for Cardiosolutions," said Jon Wilson, COO of the company. "He has vast experience pioneering new heart valve technologies and his surgical expertise in mini incision, beating heart techniques will be invaluable in introducing Cardiosolutions technology into the surgical arena."

Cardiosolutions, Inc. is headquartered in Stoughton, MA, and was founded and incubated in 2006 by STD Med, Inc., a Stoughton-based manufacturer and developer of medical technologies. In addition to Cardiosolutions, other companies that began at STD Med are Angiolink Corporation, Arthrosurface Incorporated, and Spirus Medical, Inc.

For more on Cardiosolutions, Inc. visit http://www.cardiosolutionsinc.com.


'/>"/>
SOURCE Cardiosolutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical cannabis ... the company’s executive management team with prominent executives from both inside and outside the ... Operating Officer, Ted Dumbauld , who has more than twenty years of business ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... , ... March 29, 2017 , ... The Wharton School ... and Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates ...
(Date:3/28/2017)... ... , ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert ... to find out if they are at risk for developing Type 2 diabetes. In ... sky by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- FinancialBuzz.com News Commentary  ... The U.S. could see significant economic benefits from ... by New Frontier Data, the legal cannabis market is projected to ... in the United States , as well as ... major factor that drives growth in this sector. Medical cannabis is ...
(Date:3/29/2017)... Research and Markets has announced the addition ... Outlook: 2016-2022" report to their offering. ... The global patient safety and risk ... end-user, and geography. Patient safety has become a ... field has developed significantly in the last decade and is currently ...
(Date:3/28/2017)... "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and ... market trends of the Chemotherapy Induced Neutropenia for the seven major ... ( France , Germany ... UK) and Japan , as well as rest ... world (RoW). The Report covers the therapeutics market revenue, ...
Breaking Medicine Technology: